Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Family Medicine | Genetic Disease
Disease Category: Epilepsy
Location: United States, MI
Epilepsy Research Study for Seizures
If you have epilepsy and experience seizures, you may be interested in learning more about a clinical research study that we are conducting. This study will evaluate the effectiveness of an investigational medicine for use in individuals with Treatment – Resistant Partial-Onset Epilepsy.
Qualified participants will receive:
- Study-related medication or placebo
- Study-related laboratory testing
- Study-related physical and neurological exams
This study requires nine visits over a six month period. Compensation of up to $800 is provided for time and travel to those that qualify to participate. There is also an extension study for those that complete the study which allows them to be on the investigational medicine for an additional seven months. The extension requires an additional five visits and provides for compensation of up to $500 for time and travel.
Patient Inclusion Criteria:
- Age 18-64
- Currently experiencing seizures
- Have tried at least two different medications for their seizures
NOTE: This is a partial list of inclusion criteria and participants will be subject to additional criteria.
Patient Exclusion Criteria:
- Active Hepatitis B, Hepatitis C or HIV
NOTE: This is a partial list of exclusion criteria and participants will be subject to additional criteria.
QUEST Research Institute
28595 Orchard Lake Rd
Farmington Hills, MI 48334
Research Center Information: QUEST Research Institute
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these